RecruitingNCT01163578

Biomarkers in Transplant Recipients to Improve Outcomes

Study of Biomarkers in Solid Organ and Bone Marrow Transplant Recipients to Better Treat Rejection

Sponsor

University of Pittsburgh

Enrollment

1,200 participants

Start Date

Mar 1, 2005

Study Type

OBSERVATIONAL

Conditions

Bone Marrow Transplantation Solid-organ Transplantation

Summary

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Eligibility

Plain Language Summary

Simplified for easier understanding

This study collects blood and tissue samples from organ transplant recipients — including kidney, liver, heart, and bone marrow transplants — to identify biological markers (biomarkers) that can predict transplant rejection, infection, and other complications earlier than current methods. Early detection could allow doctors to intervene before serious damage occurs. You may be eligible if: - You received an abdominal, thoracic (chest), or bone marrow transplant - You are receiving follow-up care at the University of Pittsburgh Medical Center - You are any age - You (or your parents) can read and understand the informed consent You may NOT be eligible if: - You (or your parents) are unable to read and understand the informed consent document Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.